[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500718":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":11,"centralContacts":15,"locations":24,"responsibleParty":44,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":7,"enrollmentInfo":56,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":7,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Institut Mutualiste Montsouris","OTHER",null,[9],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"No intervention for research purposes only",[12],{"name":13,"affiliation":5,"role":14},"Mariana Mirabel, MD, PhD","PRINCIPAL_INVESTIGATOR",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Isabelle Sauret","CONTACT","+33156616705","isabelle.sauret@imm.fr",{"name":22,"role":18,"phone":7,"phoneExt":7,"email":23},"Nathalie Bass","nathalie.bass@imm.fr",[25],{"facility":26,"status":27,"city":28,"state":7,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Intitut Mutualiste Montsouris","RECRUITING","Paris","75014","France","FR",{"type":33,"coordinates":34},"Point",[35,36],2.3488,48.85341,{"lat":36,"lon":35},[39,42],{"name":13,"role":18,"phone":40,"phoneExt":7,"email":41},"+33156616479","mariana.mirabel@imm.fr",{"name":43,"role":18,"phone":19,"phoneExt":7,"email":20},"Isabelle Sauret, MBs",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100500718","fast-track-cardiovascular-assessment-for-suspicion-of-cardiovascular-events-on-immunecheckpoint-inhibitors-100500718",false,"NCT05799898","Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors","Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors: Prospective Cohort Study.","FAST-TRACK","Inclusion Criteria:\n\n* all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":57,"type":58},200,"ESTIMATED","OBSERVATIONAL","Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors.\n\nLongitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors.\n\nDescription of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.",[62,63,64,65],"Cancer","Immune Checkpoint Inhibitor","Cardiovascular Complication","Immune-related Adverse Event","2023-03-23",{"date":68,"type":69},"2023-04-05","ACTUAL",{"date":71,"type":69},"2022-03-01",{"date":73,"type":58},"2030-01-01",{"name":5,"class":6},1]